Futura Medical Revenue vs. Book Value Per Share
| FUM Stock | 32.95 0.22 0.66% |
Total Revenue | First Reported 2004-01-31 | Previous Quarter 1.4 M | Current Value 7 M | Quarterly Volatility 822.5 K |
For Futura Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Futura Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Futura Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Futura Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Futura Medical over time as well as its relative position and ranking within its peers.
Futura |
Futura Medical Book Value Per Share vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Futura Medical's current stock value. Our valuation model uses many indicators to compare Futura Medical value to that of its competitors to determine the firm's financial worth. Futura Medical is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in book value per share category among its peers . The ratio of Revenue to Book Value Per Share for Futura Medical is about 119,268,000 . At present, Futura Medical's Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Futura Medical's earnings, one of the primary drivers of an investment's value.Futura Revenue vs. Competition
Futura Medical is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 753.96 Trillion. Futura Medical adds roughly 3.1 Million in revenue claiming only tiny portion of equities under Health Care industry.
Futura Book Value Per Share vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Futura Medical |
| = | 3.1 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Futura Medical |
| = | 0.03 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Futura Book Value Per Share Comparison
Futura Medical is currently under evaluation in book value per share category among its peers.
Futura Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Futura Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Futura Medical will eventually generate negative long term returns. The profitability progress is the general direction of Futura Medical's change in net profit over the period of time. It can combine multiple indicators of Futura Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 190.7 K | 200.3 K | |
| Operating Income | -7 M | -6.6 M | |
| Income Before Tax | -6.9 M | -6.5 M | |
| Total Other Income Expense Net | 71.8 K | 75.4 K | |
| Net Loss | -6.9 M | -6.5 M | |
| Income Tax Expense | -379.1 K | -398 K | |
| Net Loss | -6.5 M | -6.8 M | |
| Net Loss | -4.5 M | -4.7 M | |
| Net Interest Income | 71.8 K | 75.4 K | |
| Interest Income | 71.8 K | 75.4 K | |
| Change To Netincome | -238.7 K | -226.8 K |
Futura Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Futura Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Futura Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Futura Medical's important profitability drivers and their relationship over time.
Use Futura Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Futura Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Futura Medical will appreciate offsetting losses from the drop in the long position's value.Futura Medical Pair Trading
Futura Medical Pair Trading Analysis
The ability to find closely correlated positions to Futura Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Futura Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Futura Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Futura Medical to buy it.
The correlation of Futura Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Futura Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Futura Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Futura Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Futura Medical position
In addition to having Futura Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Futura Stock
To fully project Futura Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Futura Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Futura Medical's income statement, its balance sheet, and the statement of cash flows.